NCT03785574 2026-03-16
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
Clinical Trials
22 trialsNCT07472153 2026-03-16
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT04575935 2026-03-05
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT04857528 2026-03-04
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Recruiting
NCT07033819 2026-02-27
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT07022483 2026-02-04
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Daiichi Sankyo
Phase 3 Recruiting
NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06529809 2025-12-24
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
Washington University School of Medicine
Phase 1/2 Recruiting
NCT07167160 2025-12-18
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Recruiting
NCT06877572 2025-10-27
ECS Weight
University of Kansas Medical Center
Recruiting
NCT06686030 2025-04-16
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
Akeso
Phase 2 Recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT06560112 2025-03-12
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
Akeso
Phase 2 Recruiting
NCT05704621 2025-03-06
SOCCER-P
Korea University Guro Hospital
Phase 2 Recruiting
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT06692166 2024-11-22
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Recruiting
NCT05183984 2024-10-16
NIRVANA-1
ARCAGY/ GINECO GROUP
Phase 2 Recruiting
NCT05684731 2024-08-13
K19017-004
Tongji Hospital
Phase 1 Recruiting
NCT06376604 2024-04-19
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
L-Nutra Inc
Phase NA Recruiting
NCT05076942 2023-08-01
GROINSS-VIII
University Medical Center Groningen
Phase 2 Recruiting
NCT05733806 2023-02-23
MITO9B
National Cancer Institute, Naples
Recruiting
NCT05607329 2022-11-07
Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting